Closing Bell: Cardiol Therapeutics Inc down on Tuesday (CRDL)
Today, Cardiol Therapeutics Inc stock opened at $3.14 and closed at $3.02. prices ranged from a low of $2.91 to a high of $3.17.
Share prices eased -3.51% from the previous day's close of $3.13.
Today across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.
Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).
A total of 73,085 shares was traded during the session, with total trades of 234. On average, Cardiol Therapeutics Inc has traded 96,720 shares over 5 days and 149,897 year-to-date.
The TSX overall saw 2,584 price advancers against 2,644 declines and 86 unchanged.
During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, in the last 12 months, Cardiol Therapeutics Inc's shares have risen 111.19 percent, while they have risen 174.55% this year.
Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $217.19 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.
Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.
Currently, Cardiol Therapeutics Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
